학술논문

134P Impact of pre-operative MammaPrint/BluePrint use for final treatment decisions in patients with stage II/IIIa HR+/HER2- early-stage breast cancer eligible for neoadjuvant chemotherapy: The DETERMIND study
Document Type
Abstract
Source
In ESMO Open May 2023 8(1) Supplement 4
Subject
Language
ISSN
2059-7029